SHP-ELA-401 MPS II (Phase 4 klinische Studie)
Laufzeit: 01.01.2016 - 31.12.2021
Kurzfassung
A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients with MPS II Who Are Receiving Elaprase and Started Treatment With Elaprase at <6 Years of Age
